1. Home
  2. ASYS vs IPHA Comparison

ASYS vs IPHA Comparison

Compare ASYS & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amtech Systems Inc.

ASYS

Amtech Systems Inc.

HOLD

Current Price

$12.98

Market Cap

164.5M

Sector

Technology

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$1.50

Market Cap

160.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASYS
IPHA
Founded
1981
1999
Country
United States
France
Employees
N/A
174
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.5M
160.7M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
ASYS
IPHA
Price
$12.98
$1.50
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.75
AVG Volume (30 Days)
171.8K
12.9K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$79,364,000.00
N/A
Revenue This Year
$2.82
$28.31
Revenue Next Year
$18.75
N/A
P/E Ratio
$1,278.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.20
$1.40
52 Week High
$18.59
$2.63

Technical Indicators

Market Signals
Indicator
ASYS
IPHA
Relative Strength Index (RSI) 48.02 31.04
Support Level $11.60 N/A
Resistance Level $13.26 $1.88
Average True Range (ATR) 0.79 0.08
MACD 0.06 -0.02
Stochastic Oscillator 47.20 2.53

Price Performance

Historical Comparison
ASYS
IPHA

About ASYS Amtech Systems Inc.

Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

Share on Social Networks: